“Everyone knows the first rule of medicine is: ‘Primum non nocere’ which is translated from the Latin to mean ‘First, do no harm’.” The second rule of medicine should be: “Secundo, tardus ne me” - Thomas Sullivan, MD
Rockville, MD (PRWEB) July 31, 2012
DrFirst Chief Strategy and Privacy Officer, Thomas E. Sullivan, M.D., testified this month before an Office of the National Coordinator for Health Information Technology (ONC) hearing on identity proofing solutions for electronic prescribing of controlled substances. The topic of the hearing was “Sharing Trusted Identities in Cyberspace.”
Dr. Sullivan’s belief, expressed in his statement to the ONC, is that after the state or federal licensing of a healthcare provider has been completed and once a government approved standard identity-proofing process has been implemented within an organization, clinicians need to successfully meet the requirements only once. Then there need only be administrative processes in place to share this identity appropriately. Dr. Sullivan stated, “I believe physicians and selected other clinical providers are among the most highly credentialed and authenticated professionals in our society.”
Dr. Sullivan told the hearing panel, “Everyone knows the first rule of medicine is: ‘Primum non nocere’ which is translated from the Latin to mean ‘First, do no harm’.” Dr. Sullivan indicated the second rule of medicine should be: “Secundo, tardus ne me” meaning “Second, don’t slow me down.”
Through his work with DrFirst, the nation’s leading e-prescribing and solutions platform provider, Dr. Sullivan has become a national expert and resource on the process of physician identity proofing. Dr. Sullivan and DrFirst, in cooperation with the Massachusetts Department of Public Health, participated in a three-year pilot project designed to establish a program to electronically prescribe controlled substances. The pilot operated under a DEA waiver and was completed in the fall of 2011. DrFirst now offers EPCS Gold℠ 2.0, a platform solution for EHR and HIS vendors to provide electronic prescribing of controlled substances.
Both Dr. Sullivan and Peter N. Kaufman, M.D., DrFirst’s chief medical officer, answered questions from the hearing panel following the testimony.
A PDF of Dr. Sullivan’s comments to the ONC can be viewed at: http://healthit.hhs.gov/portal/server.pt/document/958215/oncverbal2_pdf
About DrFirst, Inc.
Founded in 2000, DrFirst is the nation's leading e-prescribing and solutions platform provider to physician practices, major health plans, health systems, hospitals, and EHR vendors. Through its Open Borders Program, DrFirst solutions integrate with over 250 EHR, practice management and HIT systems. A Surescripts Gold Certified solution provider for four consecutive years for its award-winning Rcopia electronic prescription management system, DrFirst utilizes the Surescripts network for pharmacy connectivity, health plan information and patient medication history. For more information, visit http://www.drfirst.com.